Insider · CIK 0001276840

MULROY DENNIS

Reports to the SEC for 5 companies · SAN DIEGO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001276840

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-01	ARCTArcturus Therapeutics Holdings Inc. · Employee Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+100K sh	—	—	100,000
2026-01-08	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,515 sh	$44.71	−$112K	21,852
2026-01-07	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,908 sh	$45.11	−$86.1K	17,667
2026-01-07	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,700 sh	—	—	24,367
2026-01-07	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,700 sh	—	—	20,100
2026-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+21.4K sh	—	—	21,400
2026-01-06	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,245 sh	—	—	19,575
2026-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,245 sh	—	—	5,245
2026-01-06	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+29K sh	—	—	29,000
2026-01-05	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,363 sh	$43.26	−$145K	14,330
2026-01-03	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+8,292 sh	—	—	17,693
2026-01-03	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−8,292 sh	—	—	16,585
2025-12-22	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$20.16	+$202K	19,401
2025-12-22	ANABANAPTYSBIO, INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	—	—	60,600
2025-12-22	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−10K sh	$50.00	−$500K	9,401
2025-12-16	ANABANAPTYSBIO, INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	—	—	70,600
2025-12-16	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−6,360 sh	$45.21	−$288K	9,401
2025-12-16	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−9,365 sh	$44.62	−$418K	15,761
2025-12-16	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$20.16	+$202K	25,126
2025-01-07	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+76.4K sh	—	—	76,400
2025-01-07	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+26.8K sh	—	—	26,800
2025-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,245 sh	—	—	10,490
2025-01-06	ANABANAPTYSBIO, INCF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−2,054 sh	$15.30	−$31.4K	13,802
2025-01-06	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,245 sh	—	—	15,856
2025-01-03	ANABANAPTYSBIO, INCF Tax Payment	CHIEF FINANCIAL OFFICER	FTax Payment	−3,407 sh	$14.60	−$49.7K	10,611
2025-01-03	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−8,293 sh	—	—	24,877
2025-01-03	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+8,293 sh	—	—	14,018
2024-09-16	ANABANAPTYSBIO, INC · Employee Stock Option (right to buy)M Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−10K sh	—	—	80,600
2024-09-16	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−10K sh	$40.13	−$401K	4,744
2024-09-16	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+10K sh	$20.16	+$202K	14,744
2024-09-16	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,220 sh	$38.93	−$86.4K	4,744
2024-09-14	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,000 sh	—	—	0
2024-09-14	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,000 sh	—	—	6,964
2024-07-22	ANABANAPTYSBIO, INC · Common StockA Award	CHIEF FINANCIAL OFFICER	AAward	+20K sh	—	—	20,000
2024-05-22	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−1,500 sh	$23.72	−$35.6K	964
2024-01-30	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,065 sh	$23.63	−$72.4K	964
2024-01-08	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,180 sh	$21.81	−$47.5K	4,029
2024-01-06	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+5,245 sh	—	—	6,209
2024-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−5,245 sh	—	—	15,735
2024-01-03	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+33.2K sh	—	—	33,170
2024-01-03	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+90.8K sh	—	—	90,780
2023-09-18	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−3,895 sh	$19.32	−$75.2K	964
2023-09-14	ANABANAPTYSBIO, INCM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	+6,000 sh	—	—	6,964
2023-09-14	ANABANAPTYSBIO, INC · Restricted Stock UnitM Exercise/Conversion	CHIEF FINANCIAL OFFICER	MExercise/Conversion	−6,000 sh	—	—	6,000
2023-09-14	ANABANAPTYSBIO, INCS Sale	CHIEF FINANCIAL OFFICER	SSale	−2,105 sh	$19.48	−$41K	4,859
2023-01-06	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+57.3K sh	—	—	57,260
2023-01-06	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+21K sh	—	—	20,980
2022-09-14	ANABANAPTYSBIO, INC · Restricted Stock UnitA Award	CHIEF FINANCIAL OFFICER	AAward	+12K sh	—	—	12,000
2022-06-23	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+10K sh	—	—	10,000
2022-02-10	ANABANAPTYSBIO, INC · Stock Option (right to buy)A Award	CHIEF FINANCIAL OFFICER	AAward	+70K sh	—	—	70,000

Recent filings

Accepted (ET)
May 74
MULROY DENNIS0001193805-26-000578
SEC(opens sec.gov)
Jan 94
MULROY DENNIS0001276840-26-000006
SEC(opens sec.gov)
Jan 84
MULROY DENNIS0001276840-26-000004
SEC(opens sec.gov)
Jan 64
MULROY DENNIS0001276840-26-000002
SEC(opens sec.gov)
Dec 234
MULROY DENNIS0001276840-25-000004
SEC(opens sec.gov)
Dec 184
MULROY DENNIS0001276840-25-000003
SEC(opens sec.gov)
Jan 74
MULROY DENNIS0001415889-25-001044
SEC(opens sec.gov)

Companies

Address

C/O ARCTURUS THERAPEUTICS HOLDINGS INC. 10285 SCIENCE CENTER DRIVE

SAN DIEGO, CA, 92121